1. Home
  2. CGTX vs AACG Comparison

CGTX vs AACG Comparison

Compare CGTX & AACG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CGTX
  • AACG
  • Stock Information
  • Founded
  • CGTX 2007
  • AACG 1999
  • Country
  • CGTX United States
  • AACG China
  • Employees
  • CGTX N/A
  • AACG N/A
  • Industry
  • CGTX Biotechnology: Pharmaceutical Preparations
  • AACG Other Consumer Services
  • Sector
  • CGTX Health Care
  • AACG Real Estate
  • Exchange
  • CGTX Nasdaq
  • AACG Nasdaq
  • Market Cap
  • CGTX 20.5M
  • AACG 24.4M
  • IPO Year
  • CGTX 2021
  • AACG N/A
  • Fundamental
  • Price
  • CGTX $0.41
  • AACG $0.84
  • Analyst Decision
  • CGTX Strong Buy
  • AACG
  • Analyst Count
  • CGTX 5
  • AACG 0
  • Target Price
  • CGTX $5.63
  • AACG N/A
  • AVG Volume (30 Days)
  • CGTX 2.0M
  • AACG 11.8K
  • Earning Date
  • CGTX 08-07-2025
  • AACG 08-06-2025
  • Dividend Yield
  • CGTX N/A
  • AACG N/A
  • EPS Growth
  • CGTX N/A
  • AACG N/A
  • EPS
  • CGTX N/A
  • AACG N/A
  • Revenue
  • CGTX N/A
  • AACG $37,997,003.00
  • Revenue This Year
  • CGTX N/A
  • AACG N/A
  • Revenue Next Year
  • CGTX N/A
  • AACG N/A
  • P/E Ratio
  • CGTX N/A
  • AACG N/A
  • Revenue Growth
  • CGTX N/A
  • AACG 21.24
  • 52 Week Low
  • CGTX $0.22
  • AACG $0.50
  • 52 Week High
  • CGTX $2.54
  • AACG $1.10
  • Technical
  • Relative Strength Index (RSI)
  • CGTX 67.18
  • AACG 51.28
  • Support Level
  • CGTX $0.29
  • AACG $0.83
  • Resistance Level
  • CGTX $0.34
  • AACG $0.80
  • Average True Range (ATR)
  • CGTX 0.03
  • AACG 0.03
  • MACD
  • CGTX 0.01
  • AACG 0.01
  • Stochastic Oscillator
  • CGTX 92.43
  • AACG 81.18

About CGTX Cognition Therapeutics Inc.

Cognition Therapeutics Inc is a clinical-stage biopharmaceutical company engaged in the discovery and development of, small-molecule therapeutics targeting age-related degenerative diseases and disorders of the central nervous system and retina. Its product candidate CT1812, is an orally delivered, small-molecule antagonist designed to penetrate the blood-brain barrier and bind selectively to the S2R complex.

About AACG ATA Creativity Global

ATA Creativity Global is an international educational services company focused on providing quality learning experiences that cultivate and enhance students' creativity. The operating segments of the company are (i) Overseas art study services (ii) Other educational services and (iii) Other services. Majority of its revenue comes from Overseas art study services.

Share on Social Networks: